- Joined
- Feb 20, 2021
- Messages
- 239
- Reaction score
- 672
Artificial intelligence will continue to advance at a pace that exceeds human capability. This trajectory is inevitable and unequivocal. Benefits to patients lie within harnessing AI within “Little RadOnc”. Community or smaller-scale radiation oncology practices. The most significant AI breakthroughs will likely originate from large institutions and research groups, their downstream optimization and practical application over the coming decades will increasingly empower smaller practices through software related advances.
It is a given that software advances will continue to outpace hardware advances. Creators of hardware will be opposed to this. A cautionary parallel can be drawn from the gaming industry leaders that create new systems with exclusive games/software, even with old hardware that could have ran a similar version. If this happens in medicine it could exacerbate disparities between small radonc and big radonc. We need a growing level of scrutiny applied to hardware changes, especially as they relate to data integrity, algorithmic fairness, and other nuances.
I think AI advancements could empower smaller, resource-limited practices to demonstrate equality in care and decrease need of sending patients to larger centers. Acute attention and leverage of validated AI tools may provide comparable outcomes without necessitating referrals to high-cost tertiary centers. The benefit of this? Patients remain closer to home, we don't waste money on machines that don't have true proven benefit based on biased study parameters or limitations of making software applicable to older machines in orders to build profit on hardware.
Embrace and discuss advances in medicine. Scrutinize new expensive machines that can increase billing. Prevent a need for referring by providing similar care, this will be made continually easier with software, in spite of the expenses of what could be unnecessary hardware.
It is a given that software advances will continue to outpace hardware advances. Creators of hardware will be opposed to this. A cautionary parallel can be drawn from the gaming industry leaders that create new systems with exclusive games/software, even with old hardware that could have ran a similar version. If this happens in medicine it could exacerbate disparities between small radonc and big radonc. We need a growing level of scrutiny applied to hardware changes, especially as they relate to data integrity, algorithmic fairness, and other nuances.
I think AI advancements could empower smaller, resource-limited practices to demonstrate equality in care and decrease need of sending patients to larger centers. Acute attention and leverage of validated AI tools may provide comparable outcomes without necessitating referrals to high-cost tertiary centers. The benefit of this? Patients remain closer to home, we don't waste money on machines that don't have true proven benefit based on biased study parameters or limitations of making software applicable to older machines in orders to build profit on hardware.
Embrace and discuss advances in medicine. Scrutinize new expensive machines that can increase billing. Prevent a need for referring by providing similar care, this will be made continually easier with software, in spite of the expenses of what could be unnecessary hardware.
Last edited: